Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia-Reference-Cited by-同舟云学术

Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia

Published:2013 Issue:5 Volume:19 Page:909-915
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Karino Fumi,Miura Kiyotaka,Fuchita Hiroshi,Koba Naoya,Nishikawa Emiko,Hotta Takamasa,Okimoto Tamio,Iwamoto Shinichi,Tsubata Yukari,Tada Mitsuhiro,Hamaguchi Shunichi,Honda Takeshi,Ohe Miki,Sutani Akihisa,Kuraki Takashige,Takeyama Hiroyasu,Isobe Takeshi

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s10156-013-0605-x

Reference22 articles.

1. Ministry of Health, Labour and Welfare. Specified Report of Vital Statistics in fiscal year 2007.

2. The Japanese Respiratory Society guideline for the management of nursing and healthcare-associated pneumonia;Jpn Respir Soc,2011

3. Guidelines for the management of adults with hospital- acquired, ventilator-associated, and healthcare-associated pneu- monia;Am J Respir Crit Care Med,2005

4. Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects;Kozawa;Antimicrob Agents Chemother,1998

5. Evaluation of the efficacy and safety of biapenem against pneumonia in the elderly and a study on its pharmacokinetics;Karino;J Infect Chemother,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan;Clinical Pharmacokinetics;2023-01

2. Biapenem: Clinical and Microbiological Characteristics and the Place of The New Carbapenem In The Treatment of Severe Infections In The Hospital. Clinical Pharmacologists' Point of View;Antibiotics and Chemotherapy;2022-09-09

3. Concomitant vancomycin and piperacillin/tazobactam treatment is associated with an increased risk of acute kidney injury in Japanese patients;Journal of Infection and Chemotherapy;2020-10

4. Evaluation of the risk of acute kidney injury with the use of piperacillin/tazobactam among adult critically ill patients;Infection;2020-07-22

5. Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study;Journal of Pharmaceutical Health Care and Sciences;2019-06-12